Some patients are more at risk than others of contracting nephrogenic systemic fibrosis. Patients who are most at risk include those with severe kidney problems, such as those who require transplants.

Another at risk group includes young children whose kidneys are not completely developed. For such at risk patients, doctors may be advised to be cautious in using gadolinium-based contrast agents because they may increase the chances of contracting NSF.

If you may have contracted NSF because of a gadolinium-based contrast agent, contact the gadolinium lawyers of Williams Kherkher at 800-761-3187.

An FDA-appointed panel has ruled that restrictions should be placed on the use of gadolinium contrast agents (commonly used in medical imaging scans) after convincing evidence has linked the agents to a potentially fatal skin-hardening disease called nephrogenic systemic fibrosis (NSF). Sources say that NSF is a progressive disease that can cause the skin to thicken and harden in the arms, legs, and extremities.

While the FDA does not have to follow the advice of it's appointed panels, sources say that a panel recommendation often goes a long way toward implementing new regulations. 

If you or someone you love has suffered NSF or other health problems caused by gadolinium contrast agents, contact the NSF attorneys of Williams Kherkher at 800-761-3187 today.

Medical experts affiliated with the U.S. Food and Drug Administration will consider whether new warnings should be added to certain drugs, including drugs that contain gadolinium. 

The drugs in question are made by General Electric, Bayer AG, Covidien Plc and other drug manufacturers. These drugs generate hundreds of millions of dollars in sales each year and are often used for magnetic resonance imaging. 

If you or anyone you know has suffered ill side effects from taking a gadolinium-based contast agent, contact the NSF lawyers of Williams Kherkher at 800-761-3187.

Magnetic resonance imaging scanners work by detecting various points in a patient's body and building a 2-dimensional or 3-dimensional image of the body. The image is created using magnetic imaging and radio waves. 

MRIs are a very useful diagnositc tool for doctors because they provide doctors with extraordinary detail of the body's tissues. Doctors can use this tissue to determine if there are tissue abnormalities or if the blood is not flowing properly in some part of the body. 

In some cases, doctors will use a contrasting agent to refine the image. Some of these agents, however, have been linked to cancer and other side effects.

If you or anyone you know has experienced adverse side effects resulting from a gadolinium-based agent, contact the gadolinium lawyers of Williams Kherker at 800-761-3187. 

According to a recent article in Business Week, General Electric is facing a growing number of concerns about Omniscan. The gadolinium-based drug is used in MRI scans and may be linked to nephrogenic systemic fibrosis (NSF). 

Omniscan is one of a number of similar products that is being tied to kidney disease in some patients. According to the article, GE has 30% of the drug market, while Bayer HealthCare has 50% of the market. 

If some of the cases against GE force the company to compensate victims for their injuries related to Omniscan, then the verdicts could hurt the company's growing health-care division. 

If you or anyone you know has sustained injuries after undergoing an MRI scan with a gadolinium-based agent, contact the gadolinium lawyers of Williams Kherkher at 800-761-3187. 

The FDA has released its list of drugs that are being reviewed for safety problems. These drugs include gadolinium-based contrast agents, which are used during magnetic resonance imaging. 

The FDA is investigating these drugs for potential links to anaphylaxis hypersensitivity. The drugs have already been linked to Nephrogenic Systemic Fibrosis and Nephrogenic Fibrosing Dermopathy. 

If you or anyone you know has received a gadolinium-based contrast agent, contact the NSF and NFD lawyers of Williams Kherkher at 800-761-3187.

According to a study published in the American Roentgen Ray Society, exposure to gadolinium and other contrast agents can lead to adverse effects. While the rate of incidence is low, the study confirms the potential danger of these contrast agents. While most of the injuries caused by exposure are mild and can be treated, some are more serious and require serious medical attention.

The study was conducted by three researchers from the Mayo Clinic's Department of Radiology. The paper was titled "Frequency and Severity of Adverse Effects of Iodinated and Gadolinium Contrast Materials: Retrospective Review of 456,930 Doses." 

If you or anyone you know has been exposed to gadolinium and has suffered adverse effects, contact the NSF and NSD lawyers of Williams & Kherkher 800-761-3187.